TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/04/2025
Voltar para busca
Dado oficial do USPTO
CHANGING TOMORROW
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
CHANGING TOMORROW
ST13
US500000085832274Classe
5, 16, 35, 36, 41, 42, 44
Pedido
85832274
Registro
4442676
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
33
Atualização mais recente
16/04/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 16, 35, 36, 41, 42, 44
Data de depósito
25/01/2013
Data de registro
03/12/2013
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
10/08/2023
Última transação
16/04/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
800
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
03
Localização do titular
Tokyo, JP
Examinador
MARTIN, CHRISTINE
Unidade examinadora
L40
Localização atual
GENERIC WEB UPDATE
Titulares e representantes
Titulares
Astellas Pharma Inc.
Representantes
Christopher Bolinger Astellas Pharma Inc.
Classificação técnica
Classes Nice
Classe 5Classe 16Classe 35Classe 36Classe 41Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparations for the treatment of the central nervous system diseasespsychiatric diseasescentral nervous system infectionsbrain diseasescentral nervous system movement disordersocular motility disordersspinal cord diseasescentral nervous system neuropathic pain; pharmaceutical preparations for the treatment of the peripheral nervous system diseasespoly neuropathyfacial paralysisentrapment neuropathyperipheral nervous system neuropathic pain; pharmaceutical preparations for the treatment of the sensory organshearing lossacute pain; pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceutical preparations for the treatment of the respiratory system; pharmaceutical preparations for use in gastroenteritis; pharmaceutical preparations of hormones for use in the treatment of infertility; pharmaceutical preparations for the treatment of genitourinary diseasesinfertilitysexually transmitted diseasesinflammatory pelvic diseases; pharmaceutical preparations for the treatment of urological diseasesbenign prostatic hyperplasiaover active bladder; pharmaceutical preparations for use in dermatologydermatitisskin pigmentation diseasesacne medication; pharmaceutical preparations for the treatment of hematological diseasesanemia; pharmaceutical preparations for the treatment of immunological diseasesrejection in transplantationautoimmune diseasesimmunologic deficiency syndromesallergy medication; vitamins; pharmaceutical preparations for the treatment of metabolic disorders; pharmaceutical preparations for the treatment of cancertumor suppressing agents; antibioticsantifungalsanti-viral drugs; vaccines for the treatment of infectious diseases; diagnostic preparations for medical purposes for use in testing urinefecal occult blood and other blood diseasesanemialeukemiahemophilia; pharmaceuticals for human useanthelmintics; sanitary preparationsgermicides
Classe 16
Printed pamphletsbrochuresmanualsbooksbookletsleafletsflyersinformational sheets and newslettersadhesive backed stickerskits comprising one or more of the foregoing materials in the field of pharmaceuticals
Classe 35
Providing information on pharmaceuticals sales and other commodity sales
Classe 36
Offering a subsidy to medical servicesproviding financial assistance to disadvantaged persons for health care; investigation for offering a subsidyproviding information about the provision of financial assistance to disadvantaged persons for health care; development and running projects for offering a subsidyadministering monetary charitable contributions for disadvantaged persons for healthcare; charitable fund raising
Classe 41
Educational and instruction servicesproviding classesseminarsworkshop relating to pharmaceuticalshealthmedical treatments and health care; educational servicesarrangingconducting and organization of seminarsforumssymposiumsacademic conferences and lecture meetings in the fields of pharmaceuticalshealthmedical treatments and health care
Classe 42
Testinginspection or research of pharmaceuticals; providing information relating to testinginspection or research of pharmaceuticals; providing information relating to testinginspection or research in the fields of medicinepharmaceuticalsmedical treatments and health care
Classe 44
Providing information relating to medical treatments and health care; providing medical information relating to pharmaceuticals: providing medical information
Publicações
Histórico de despachos e eventos da marca no USPTO.
33 publicações encontradas
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
10/04/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/04/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/04/2025
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
10/08/2023
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
10/08/2023
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
10/08/2023
E89R
TEAS SECTION 8 & 9 RECEIVED
09/08/2023
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
03/12/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/06/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
03/06/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/06/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/06/2022
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
28/01/2020
C15P
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
28/01/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
28/01/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/12/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/12/2019
E815
TEAS SECTION 8 & 15 RECEIVED
03/12/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
03/12/2013
PUBO
PUBLISHED FOR OPPOSITION
17/09/2013
NPUB
NOTICE OF PUBLICATION
28/08/2013
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
15/08/2013
ALIE
ASSIGNED TO LIE
15/08/2013
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/08/2013
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
31/07/2013
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
30/07/2013
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
30/07/2013
CNRT
NON-FINAL ACTION MAILED
13/02/2013
CNRT
NON-FINAL ACTION WRITTEN
13/02/2013
DOCK
ASSIGNED TO EXAMINER
11/02/2013
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
31/01/2013
NWAP
NEW APPLICATION ENTERED
29/01/2013
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace CHANGING TOMORROW ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.